Skip to content
PIL Logo

VFEND 50mg and 200mg film-coated tablets

Last Updated on eMC 03-Mar-2017 View document  | Pfizer Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03-Mar-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 03-Mar-2017 and displayed until 03-Mar-2017

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 21-Jun-2016 and displayed until 03-Mar-2017

Reasons for adding or updating:

  • Change to section 6 - date of revision

Updated on 18-Dec-2015 and displayed until 21-Jun-2016

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 25-Jun-2015 and displayed until 18-Dec-2015

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 07-Oct-2014 and displayed until 25-Jun-2015

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 04-Sep-2014 and displayed until 07-Oct-2014

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Updated on 04-Sep-2014 and displayed until 04-Sep-2014

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 27-Aug-2014 and displayed until 04-Sep-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 02-Jul-2014 and displayed until 27-Aug-2014

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 21-Feb-2014 and displayed until 02-Jul-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 04-Dec-2013 and displayed until 21-Feb-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 01-Aug-2013 and displayed until 04-Dec-2013

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 12-Nov-2012 and displayed until 01-Aug-2013

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Introduction of new pack/pack size

Updated on 27-Feb-2012 and displayed until 12-Nov-2012

Reasons for adding or updating:

  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions

Updated on 09-Jan-2012 and displayed until 27-Feb-2012

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to, or new, use for medicine
  • Change to dosage and administration

Updated on 13-Sep-2011 and displayed until 09-Jan-2012

Reasons for adding or updating:

  • Change to drug interactions

Updated on 17-Jan-2011 and displayed until 13-Sep-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to drug interactions

Updated on 14-Sep-2010 and displayed until 17-Jan-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration

Updated on 24-Feb-2009 and displayed until 14-Sep-2010

Reasons for adding or updating:

  • Change to date of revision
  • Change to drug interactions

Updated on 13-Nov-2008 and displayed until 24-Feb-2009

Reasons for adding or updating:

  • Change to date of revision
  • Change to name of manufacturer

Updated on 17-Apr-2008 and displayed until 13-Nov-2008

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 21-Feb-2008 and displayed until 17-Apr-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to date of revision

Updated on 25-Jul-2007 and displayed until 21-Feb-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
  • PIL Retired combination of strengths

Updated on 14-Jun-2007 and displayed until 25-Jul-2007

Reasons for adding or updating:

  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Change to dosage and administration
  • Change to how to administer the medicine
  • Change of special precautions for disposal
  • Improved Electronic Presentation

Updated on 26-Sep-2006 and displayed until 14-Jun-2007

Reasons for adding or updating:

  • Change to manufacturer contact details

Updated on 07-Aug-2006 and displayed until 26-Sep-2006

Reasons for adding or updating:

  • Change to drug interactions

Updated on 28-Jul-2006 and displayed until 07-Aug-2006

Reasons for adding or updating:

  • Change to drug interactions

Updated on 01-Mar-2006 and displayed until 28-Jul-2006

Reasons for adding or updating:

  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Change to Further Information section

Updated on 31-May-2005 and displayed until 01-Mar-2006

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Pfizer Limited

Company image
Address

Ramsgate Road, Sandwich, Kent, CT13 9NJ

Fax

+44 (0)1304 656 221

Telephone

+44 (0)1304 616 161

Medical Information Website

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

voriconazole

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue